Rubicon Research IPO price band is set at ₹461 to ₹485 per share. Rubicon Research IPO GMP remains strong at more than 20% on ...

Rubicon Research is a pharmaceutical formulation company with a strong focus on R&D and innovation. Its portfolio includes an ...

Canara HSBC Life Insurance, Rubicon Research, and Canara Robeco AMC IPOs are generating interest amid ongoing market activity ...

The IPO is a book-building issue of Rs 1,377.50 crore, which includes a fresh issue of 1.03 crore equity shares worth Rs 500 ...

According to current GMP trends, the grey market premium for the Rubicon Research IPO has been strong for the last few days and showed minor gains when the mainboard issue opened for subscription.

Rubicon Research's IPO, amounting to Rs 1,377.5 crore, was fully subscribed on the second day. The retail investor category ...

Rubicon Research IPO has garnered significant investor attention, oversubscribing by day two and indicating strong market ...

The maiden share sale of the pharma company is set to remain available for subscription until October 13, 2025. Following ...

Rubicon Research’s ₹ IPO issue was subscribed 84% on the second day, with strong demand from retail investors. The company’s ...

Rubicon Research's IPO saw strong investor demand, subscribed 2.37 times. The pharma firm specializes in generics and ...

Rubicon Research IPO Opens Today for Subscription: The Mumbai-based pharmaceutical company, Rubicon Research Limited, is ...

Analysts have also shared favourable views on the IPO, boosting investor sentiment ahead of the launch of the offering ...